TITAN decreaser macroinvertebrate heatmap Heatmap of sensitive (i.e., <i>z-</i>) macroinvertebrate taxa (y-axis) to at least one of the five stressors, in decreasing order of numbe... حسب Brent J. Bellinger (21156150)

Pipeline of the 3D reconstruction. حسب Elodie Perdreau (15347854)

"…Macroscopic assessment of devices showed that the coverage was complete for the left-side disk in all cases. Yet incomplete coverage of the right-side disk was observed in 5 of the 8 cases. 2D and 3D micro-CT analysis allowed an accurate evaluation of device coverage of each disk and was overall well correlated to histology sections. …"

Data of the eight animals included in the study. حسب Elodie Perdreau (15347854)

"…Macroscopic assessment of devices showed that the coverage was complete for the left-side disk in all cases. Yet incomplete coverage of the right-side disk was observed in 5 of the 8 cases. 2D and 3D micro-CT analysis allowed an accurate evaluation of device coverage of each disk and was overall well correlated to histology sections. …"

Flow chart of the study. حسب Elodie Perdreau (15347854)

"…Macroscopic assessment of devices showed that the coverage was complete for the left-side disk in all cases. Yet incomplete coverage of the right-side disk was observed in 5 of the 8 cases. 2D and 3D micro-CT analysis allowed an accurate evaluation of device coverage of each disk and was overall well correlated to histology sections. …"

Method for the Large-Scale Synthesis of Multifunctional 1,4-Dihydro-pyrrolo[3,2‑<i>b</i>]pyrroles حسب Mariusz Tasior (1457731)

"…A thorough investigation has enabled the optimization of the synthesis of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles. Although salts of such metals as vanadium, niobium, cerium, and manganese were found to facilitate the formation of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles from amines, aldehydes, and diacetyl, we confirmed that iron salts are the most efficient catalysts. …"

Method for the Large-Scale Synthesis of Multifunctional 1,4-Dihydro-pyrrolo[3,2‑<i>b</i>]pyrroles حسب Mariusz Tasior (1457731)

"…A thorough investigation has enabled the optimization of the synthesis of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles. Although salts of such metals as vanadium, niobium, cerium, and manganese were found to facilitate the formation of 1,4-dihydro-pyrrolo­[3,2-<i>b</i>]­pyrroles from amines, aldehydes, and diacetyl, we confirmed that iron salts are the most efficient catalysts. …"

Benchmarking DFT Accuracy in Predicting O 1s Binding Energies on Metals حسب Elizabeth E. Happel (22391811)

الموضوعات:

Benchmarking DFT Accuracy in Predicting O 1s Binding Energies on Metals حسب Elizabeth E. Happel (22391811)

الموضوعات:

Simulation results (1^st case). حسب Tuan Anh Nguyen (121944)

الموضوعات:

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( حسب Farrokh Habibzadeh (12256529)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Model diagnostics for all death events. حسب Xin Zhang (35492)

"…Moreover, composite pollutants exhibited a higher risk effect, reaching its peak after one week; however, there was a decrease in single-day cumulative effects as more pollutant types were included. …"

Simulation results (1^st case). حسب Tuan Anh Nguyen (121944)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. حسب Simon K. Schnyder (16632244)

Typical cases of normal esophageal diameter. حسب Hiromichi Hara (768931)

Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments حسب Steven R. Shuken (14500192)

"…We show how increasing sample size, decreasing variability, or increasing effect size can enable the detection of all true changes while still correcting <i>p</i>-values, and we present basic guidelines for omic experimental design. …"

Patient journey–Admission to discharge (all cases). حسب Olive Kabajaasi (4575343)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)